Accessibility Menu
PolyNovo logo

PolyNovo

(ASX) PNV

Current PriceA$0.97
Market CapA$666.66M
Since IPO (1998)+405%
5 Year-63%
1 Year-24%
1 Month-4%

PolyNovo Financials at a Glance

Market Cap

A$666.66M

Revenue (TTM)

A$253.51M

Net Income (TTM)

A$15.78M

EPS (TTM)

A$0.01

P/E Ratio

67.48

Dividend

A$0.00

Beta (Volatility)

0.17 (Low)

Price

A$0.97

Volume

3,715,486

Open

A$1.04

Previous Close

A$0.97

Daily Range

A$0.96 - A$1.05

52-Week Range

A$0.87 - A$1.67

Estimated Earnings Date

Aug 21, 2026

PNV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PolyNovo

Industry

Healthcare Equipment and Supplies

Employees

301

CEO

Robyn Elliott, PhD

Headquarters

Port Melbourne, VIC 3207, AU

PNV Financials

Key Financial Metrics (TTM)

Gross Margin

32%

Operating Margin

2%

Net Income Margin

7%

Return on Equity

12%

Return on Capital

3%

Return on Assets

8%

Earnings Yield

1.48%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$666.66M

Shares Outstanding

690.84M

Volume

3.72M

Avg. Volume

2.79M

Financials (TTM)

Gross Profit

A$122.05M

Operating Income

A$4.48M

EBITDA

A$10.45M

Operating Cash Flow

A$3.15M

Capital Expenditure

-A$13.93M

Free Cash Flow

-A$10.78M

Cash & ST Invst.

A$33.59M

Total Debt

A$17.14M

PolyNovo Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$70.20M

+48.9%

Gross Profit

A$21.46M

+29.3%

Gross Margin

30.57%

N/A

Market Cap

A$666.66M

N/A

Market Cap/Employee

A$2.36M

N/A

Employees

282

N/A

Net Income

A$3.00K

-99.9%

EBITDA

A$3.36M

+34.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$29.26M

-35.9%

Total Debt

A$31.74M

+107.0%

Accounts Receivable

A$24.21M

+70.8%

Inventory

A$11.85M

+72.1%

Long Term Debt

A$28.94M

+111.3%

Short Term Debt

A$2.80M

+71.2%

Return on Assets

8.01%

N/A

Return on Invested Capital

2.72%

N/A

Free Cash Flow

-A$1.62M

-3408.2%

Operating Cash Flow

A$9.16M

+688.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PYC.AXPYC Therapeutics Limited
A$1.22+3.39%
IDX.AXIntegral Diagnostics Limited
A$2.04+0.49%
AVR.AXAnteris Technologies Ltd
A$13.12-2.81%
IMR.AXImricor Medical Systems, Inc.
A$1.75+4.17%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$160.95+0.19%
AALAmerican Airlines Group
$14.98+0.02%
NOKNokia
$14.80+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%

Questions About PNV

What is the current price of PolyNovo?

PolyNovo is trading at A$0.97 per share.

What is the 52-week range for PolyNovo?

Over the past 52 weeks, PolyNovo has traded between A$0.87 and A$1.67.

How much debt does PolyNovo have?

As of the most recent reporting period, PolyNovo reported total debt of A$17.14M.

How much cash does PolyNovo have on hand?

PolyNovo reported A$33.53M in cash and cash equivalents in its most recent financial results.

What is PolyNovo’s dividend yield?

PolyNovo does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.